Events

A new targeted oral therapy is changing the landscape for people with hormone receptor positive, HER2 negative metastatic breast cancer, offering another option for those whose disease has progressed on prior treatment. This practical session will step through how the treatment works, when it is used and what makes its side effect profile distinct.